Compounds > n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
Page last updated: 2024-10-28

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Uterine Neoplasms

n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide has been researched along with Uterine Neoplasms in 1 studies

Uterine Neoplasms: Tumors or cancer of the UTERUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taniguchi, T1
Matsuzaki, N1
Jo, T1
Saji, F1
Taga, T1
Hirano, T1
Kishimoto, T1
Tanizawa, O1

Other Studies

1 other study available for n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide and Uterine Neoplasms

ArticleYear
Interleukin-1 (IL-1)-induced IL-6- and IL-6-receptor-mediated release of human chorionic gonadotropin by choriocarcinoma cell lines (Jar and HCCM-5) activates adenosine 3',5'-monophosphate-independent signal transduction pathway.
    The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Choriocarcinoma; Chorionic Gonadotropin; Cyclic A

1992